Alabama's medical cannabis program will expand to five dispensaries this week with the opening of two new locations, state officials announced Thursday.
Justin Aday, general counsel for the Alabama Medical Cannabis Commission, confirmed the expansion during a commission meeting. The new dispensaries mark a significant step in the state's rollout of medical marijuana access, which began in late 2023 after years of legislative delays.
"We've also been doing some other educational work with the physicians…making sure that they're comfortable with the patient registry and the different requirements under the law," Aday said.
Slow But Steady Expansion
Alabama's medical cannabis program has grown methodically since its inception. The state initially licensed three dispensaries, which opened in late 2023 and early 2024. The addition of two more locations doubles the original footprint, though the state remains behind neighboring programs in terms of access points.
The Medical Cannabis Commission has prioritized regulatory compliance and physician education over rapid expansion. Officials have spent considerable time working with healthcare providers to ensure they understand certification requirements and the patient registry system, which tracks all medical cannabis recommendations statewide.
Alabama's qualifying conditions include cancer, chronic pain, PTSD, epilepsy, and several other serious medical conditions. The program does not allow home cultivation or smokable flower, limiting patients to oils, capsules, and other processed forms.
Industry Response
The measured pace of Alabama's rollout has drawn mixed reactions from industry stakeholders. Some dispensary operators and patient advocates have called for faster licensing and broader access, particularly in rural areas where patients may need to drive hours to reach the nearest location.
But state officials have defended their approach, emphasizing the importance of establishing a stable regulatory framework before scaling up. The commission has also faced logistical challenges, including limited testing laboratory capacity and supply chain bottlenecks that affected initial product availability.
The state's cultivation facilities have gradually increased production to meet growing demand. Early reports suggested product shortages at some dispensaries, though officials say supply has stabilized in recent months as more processors and cultivators come online.
What's Next
The commission has not announced a timeline for additional dispensary licenses, though officials indicated they are monitoring patient enrollment numbers and market demand. Alabama currently has several thousand registered patients, a number expected to grow as physician participation increases and awareness spreads.
Physician education remains a priority. Many doctors have been hesitant to certify patients for medical cannabis, citing concerns about federal law and limited clinical research on cannabis efficacy. The commission has responded with training sessions and informational materials designed to address these concerns and clarify state-level protections for participating physicians.
The expansion comes as several Southern states reconsider their cannabis policies. Georgia recently expanded its low-THC oil program, while Mississippi continues to build out its medical marijuana infrastructure following voter approval in 2020. Alabama's conservative approach contrasts with more aggressive rollouts in states like Missouri and Oklahoma, which licensed dozens of dispensaries within their first year.
For now, the focus remains on incremental growth and regulatory stability. The two new dispensaries will provide additional access points for patients, but the state's overall program remains one of the most restrictive in the nation.
This article is based on original reporting by www.marijuanamoment.net.
